Medicus Pharma Ltd. (MDCX): debt financing — Medicus Pharma issues third debenture for $2.5M, completing $5M Yorkville facility

Medicus Pharma Ltd.

On June 17, 2025, issued third debenture to YA II PN, Ltd. for $2.5M principal, net proceeds $2.25M.
Total aggregate principal from three debentures now $5M; net proceeds to Company $4.5M.
Debentures bear 8% annual interest (18% upon default), mature February 2, 2026, guaranteed by subsidiaries.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Medicus Pharma Ltd. incurred credit facility of $2,500,000 with YA II PN, Ltd. at 8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc maturing February 2, 2026.

Instrument: credit facility
Principal: $2,500,000
Counterparty: YA II PN, Ltd.
Rate: 8.00% per annum, subject to a potential increase to 18.00% per annum upon the oc
Maturity: February 2, 2026
Event: incurrence

Exact text from the filing

On June 17, 2025, Yorkville purchased and the Company issued a third Debenture in aggregate principal amount of $2,500,000, such amount being the remaining amount available pursuant to the Purchase Agreement, for net proceeds to the Company of $2,250,000

View on SEC.gov

73 debt financings filed in the last 30 days. Browse all debt financings →

Medicus Pharma Ltd. filing history →

Source: SEC EDGAR

accession 0001062993-25-011991

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.